Drug Target Review
NOVEMBER 27, 2023
a biopharmaceutical company, since February 2015. Dr Worland was an NIH postdoctoral fellow in molecular biology at Harvard University and completed a Ph.D. Prior to Anadys Pharmaceuticals, Inc., Dr Worland was Vice President and Head of Antiviral Research at Pfizer Inc. and Vice President at WarnerLambert Co.,
The Pharma Data
NOVEMBER 23, 2020
Zhang, who founded Legend Biotech in 2015 as a subsidiary of parent company GenScript, a company he also co-founded, had been under residential surveillance in connection with an investigation by the Customs Anti-Smuggling Department of Zhenjiang in China since Sept. as a director of molecular biology.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Target Review
OCTOBER 3, 2024
2015 May;521(7552):274–6. Methods in Molecular Biology. Journal of Molecular Biology. FDA no longer needs to require animal tests before human drug trials [Internet]. www.science.org. Available from: [link] Baker M. Reproducibility crisis: Blame it on the antibodies. Bradbury ARM, Trinklein ND, Thie H, et al.
Drug Target Review
AUGUST 29, 2024
He holds multiple utility and design patents for scientific technologies and has authored various peer-reviewed manuscripts in the fields of bacteriology, virology, immunology, molecular biology, and cancer immunotherapy.
The Pharma Data
SEPTEMBER 15, 2020
“When Amgen first partnered with us in 2015, MBC BioLabs was a single site in San Francisco hosting 40 companies. Each site has a complete molecular biology core facility that allows companies to do experiments on day one, not year one.
Codon
JUNE 5, 2025
Cas12 Discovery Cas12 was initially characterized in 2015 by Feng Zhang’s lab at the Broad Institute 5 and was quickly adopted as a complementary genome editor to Cas9. in Molecular Biology from Princeton University and also writes about science fact and fiction on Substack. He earned his A.B.
DrugBaron
NOVEMBER 22, 2022
In 2015, Methuselah Health was founded to investigate the role of proteome instability during ageing, and the extent to which the instability of specific proteins might underlie development of age-related diseases – a concept that arose from the ground-breaking work of Professor Miro Radman (which DrugBaron highlighted previously).
Expert insights. Personalized for you.
86 
Let's personalize your content